ArticleAmerican journal of cancer research2025
Establishment and validation of a recurrence risk model in early-stage tongue squamous cell carcinoma patients incorporating immune-inflammatory biomarkers and clinicopathological parameters.
Xiangxiang Liao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.